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MANY renowned surgeons have directed attention to the subject of gastric
carcinoma since Billroth performed the first successful partial gastrectonmy for
this lesion in 1881 (Billroth, 1881) and Schlatter accomplished the first total
gastrectomy in 1897. Although advances have been made in the diagnosis and
treatment of gastric cancer since the work of these pioneers, I am sure we would
all agree that even our most competent efforts of today leave nmuch to be desired.
It is natural that the names of surgeons are prominent in the literature relating
to gastric malignant disease, since no patient, to my knowledge, has ever been
cured of gastric carcinoma exccpt by surgical removal of the growth. Although
a review of past work is always of interest, no historical account will be given
at this time, as I would prefer to discuss some current controversial phases and
to report on experiences which my associates and I have had in the recognition
and management of patients who have gastric cancer.
Etiologic factors that might be responsible for development of various types
of malignant lesions have been the object of many detailed and specific studies.
Certain general data also stimulate thought and might possibly provide clues
regarding etiology if they could be properly studied and evaluated. For example,
there has been much comment during recent years about the increased incidence
of pulmonary cancer. Equally intriguing is the great difference in relative
incidence of gastric carcinoma in various countries. Interesting also, and possibly
presenting easier investigative possibilities, is the difference noted in relative
incidence of gastric carcinoma in various parts of the same country (Haenszel,
1958). The age-adjusted death rate froIm cancer of the stomach is highest in
Japan, Finland, and Chile. In fact, it was found that during the years 1951 to
1954 it was between two to three tinmes higher in these countries than it was in
Ireland, England, or the United States. An undoubtedlv significant but un-
explained fact is that age-adjusted death rates for cancer of the stomach have
decreased significantlv in some countries but not in others (Moore, 1962; Segi,
1960) (see figure). This decrease started in the United States thirty or more years
ago and has been rather pronounced. In contrast, the same change has not
occurred in Northern Ireland or England (Segi, 1960). Many theories have been
advanced to explain the geographic and national differences in the relative
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frequency and changing incidence of deaths from cancer of the stomach, but
no well-substantiated explanation has been forthcoming. As might be expected,
the role played by diet and dietary habits has been the source of much
speculation.
That many patients have been cured of gastric carcinoma for five, ten, fifteen
years or longer by appropriate surgical treatment is well attested by the literature
(Brown et al., 1961; Eker and Efskind, 1960; Fly et al., 1958; Gage et al., 1956;
Lewin, 1960; Merlo et al., 1960; Pack and McNeer, 1948; Walters et al., 1942;
Welch and Wilkins, 1958). This is an important fact to remember since a defeatist
attitude concerning gastric carcinoma is sometimes expressed. Some authors state
that "biologic predeterminism" rather than the time or type of operation governs
end results in gastric carcinoma (McDonald and Kotin, 1954). While the balance
between host resistance and tumour aggression is an admittedly important factor
in the outcome of any patient who has a malignant lesion, it is not, I believe,
the only factor which influences prognosis. The surgeon's viewpoint in this matter
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5is of some importance, since it may significantly influence his entire approach
to a patient who might have carcinoma of the stomach.
DURATION OF SYMPTOMS IN RELATION TO SURGICAL TREATMENT AND
SURVIVAL RATES AFTER RESEC-rION OF GASTRIC CANCER.
The theory of "biologic predeterminism" in regard to patients having gastric
carcinoma has been supported repeatedly in the literature by statements that a
long preoperative history affords as good or better chance for five-year survival
after surgical removal of the lesion than does a short preoperative history (Blalock
and Ochsner, 1957; Brown et al., 1961; McDonald and Kotin, 1954; McNeer
et al., 1958). It might be added that other reports of this type have been made
which have not been limited to gastric malignant lesions (Cabot and Berkson,
1939). Observations of this type obviously conflict with the long-accepted view
that early diagnosis and treatment are important in prognosis for the patient who
has a malignant lesion.
Further study of the significance of duration of symptoms prior to surgical
treatment for gastric carcinoma was undertaken recently (Barber et al., 1961)
and led to some interesting findings. The records of all patients having a diagnosis
of gastric carcinoma and seen initially at the Mayo Clinic during the years 1950
through 1953 wvere reviewed. There were 1,121 patients in all; 928 (82.8 per cent.)
were operated on, and gastric resection was performed in 572, which was 61.6
per cent. of those operated on and 51 per cent. of the total group.
It was found, as in previous studies, that the percentage of patients considered
clinically to have an inoperable lesion and who therefore were not subjected
to operation (17.2 per cent. of the total group of 1,121 patients) was virtually
the same, whether symptoms had been present for two months or less prior to
operation, or for three to five months, six to eleven months or one year or longer.
The same was true for patients who had undergone gastric resection, some
palliative surgical procedure, or only abdominal exploration. Obviously such
findings do not suggest that early diagnosis is important in the outlook for the
patient with gastric cancer. Likewise, when patients who had undergone gastric
resection for gastric carcinoma were divided into groups according to duration
of preoperative symptoms, it was found that those who had a short history prior
to operation had no better five-year survival rate than those who had a long
history.
In further search of some explanation for these findings, earlier studies on
patients who had small gastric cancers were recalled (Comfort et al., 1957; Gage
et al., 1956). In these studies it was noted that approximately 25 per cent. of
1,541 gastric adenocarcinomas removed during a ten-year period measured 4 cm.
or less in their greatest diameter. It was also noted that the postoperative five-year
survival rate for patients who had gastric carcinomas that measured 4 cm. or
smaller was definitely higher than that for patients whose lesions were larger
than 4 cm. It is known that many patients with small gastric carcinomas (4 cm.
or less in diameter) have a long history suggestive of gastric ulcer, a diagnosis
which has been made previously in many oif these patients. When five-year
130survival rates are determined separately for patients who are found to have small
(4 cm. or less in diameter) gastric cancers and those who have larger lesions,
a significant difference is noted, depending on the duration of symptoms prior
to operation.
Thus, it was found that the five-year survival rate was 24.3 per cent. for 305
patients who had symptoms of less than twelve months' duration prior to
operation and who had carcinomatous lesions that were more than 4 cm. in
diameter. In contrast, the five-year survival rate was only 11.9 per cent. for 101
patients who underwent removal of lesions of the same size but who had pre-
operative symptoms for twelve months or longer. This is in contrast with those
patients who had gastric carcinomas 4 cm. or less in diameter. In this group it
was found that only 28.6 per cent. of those who had symptoms of two months'
duration or less survived five years after removal of the lesion, whereas 59.6
per cent. of those who had symptoms for three months or longer prior to
operation survived five years or more. In this study it wvas also found that the
entire group of patients with small gastric cancers (4 cm. or less in diameter)
had a five-year survival rate of 54.2 per cent. after removal of the lesion in
contrast to a five-year survival rate of only 21.2 per cent. for those who had
larger carcinomas resected. Forty-five per cent. of patients with small lesions
had symptoms for more than one year prior to operation in contrast with only
25 per cent. of those who had larger lesions.
Consideration of these data affords some clarification of the numerous reports
referred to previously which indicate that a short preoperative history does not
improve the outlook for the plitient with gastric cancer. Without going into
detail, it might be added that although in our experience only 25 per cent. of the
patients who have had gastric cancer resected have had a lesion that measured
4 cm. or less in diameter, a relatively large percentage (43 per cent.) of all
so-called five-year cures of gastric carcinoma, regardless of size, have come from
this group. Patients with these small lesions, as a group, present a definitely
longer historv of symptoms than those patients who have larger lesions. Without
endeavouring to be specific, it seems obvious that certain fundamental differences
exist between the small gastric cancer and the larger lesion. It is also known that
the duration of symptonms is not necessarily synoniymous with the duration of
the malignant process. It appears likely that many patients found to have a small
gastric cancer at the time of operation may have had symptoms caused by benign
gastric ulcer prior to development of gastric cancer.
Much evidence, accumulated over many years, indicates that removal of gastric
cancer before extension to the serosa, lymph nodes, or adjacent structures has
occurred provides a better prognosis than operation performed after spread to
these regions. Detection of gastric cancer in a truly early stage probably requires
its discovery before symptoms occur, which poses a large problem. Even though
considered desirable, which is highly doubtful, it is not feasible to perform
rcentgenologic examination of the stomach periodically on all adults. On the
other hand, such studies on selected persons have yielded some interesting results.
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Detection Centre of the University of Minnesota on persons 50 years of age or
older who have achlorhydria or pronounced hypochlorhydria after stimulation
with histamine. A study from 1948 to 1956 showed some gastric abnormality
in 5.6 per cent. of all patients in whom rcentgenologic examination of the
stomach was performed (Hitchcock, 1957). An actual gastric malignant lesion
was discovered in 20 per cent. of the persons whose rcentgenograms showed
evidence of a gastric abnormality or 1.1 per cent. of the entire group. The
commonest lesions found were gastric polyps, gastric ulcers, gastric malignant
lesions and a "suspicious area" in the stomach. As this entire group of patients
is followed longer, it seems likely that additional abnormal findings will occur.
Of the patients in whom gastric malignant lesions were found and removed
surgically, only 10 per cent. had involvement of the lymph nodes. This is in
sharp contrast with those in whom operation had been performed after the
existence of symptoms for variable periods. The relatively frequent association
of pernicious anzemia and gastric cancer is adequate reason for all patients with
pernicious anaemia to have periodic rcentgenologic examinations of the stomach.
I believe the evidence suggests that early diagnosis and surgical treatment are
of value for the patient who has gastric cancer.
GASTRIC ULCER AND OTHER PRESUMED BENIGN CONDITIONS.
Another broad subject which has received much attention for years concerns
the differential diagnosis of benign gastric ulcer, the relationship which this
lesion may have to gastric cancer, and appropriate management of the patient
who is found to have gastric ulcers. Without going into detail, I might say that
it is my opinion that surgical treatment usually is advisable for the patient who
has a chronic gastric ulcer. This view is held (1) because long-range results of
medical treatment for gastric ulcer leave much to be desired, (2) because of the
possibility that a malignant lesion is being overlooked, (3) because of the low risk
of operation, and (4) because favourable results are obtained by surgical treatment.
In a careful study of 664 patients treated medically for presumed benign gastric
ulcer and followed for five to eleven years after institution of medical treatment,
it was found by Larson, Cain, and Bartholomew (1961) that only 21.7 per cent.
had complete symptomatic relief with permanent healing of the ulcer. Operation
became necessary in 43 per cent. of the 664 patients, and gastric cancer was
found subsequently in 8.9 per cent. of the entire group. In a smaller group of
391 patients who were treated medically for gastric ulcer and who were followed
for ten to nineteen years, the rate of incidence of gastric cancer was 12.2 per cent.
(Larson et al., 1961). Surgical treatment of patients with chronic gastric ulcer
not only affords lasting relief of symptoms in a high percentage of patients but
also permits removal of a lesion which might subsequently prove to be malignant.
If a malignant lesion actually is found at operation, its removal is accomplished
at a time that offers a more favourable prognosis than could be offered if operation
were postponed for months or longer.
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a serious and extensive lesion has developed, the gastric polyp probablyT has not
received adequate attention. One study on gastric polyps indicated that of three
hundred patients in whom the rcentgenologic diagnosis of gastric polyp or polyps
was made and operation subsequently was performed, approximately 60 per cent.
were found to have polyps, 20 per cent. other benign lesions, and 20 per cent.
a malignant lesion (Huppler et al., 1960). It is apparent from this study that the
rcentgenologic diagnosis of gastric polvp includes some patients who actually,
have malignant lesions. There were 206 of the three hundred patients in this study
who were found to have gastric polyps at the time of operation and in twentv-five
of these (12 per cent.) the polyps showed evidence of malignant change. The
rate of incidence of malignant disease was found to be 14 per cent. when
multiple polyps were present, in contrast with 9 per cent. wvhen there was only
a single polyp. In ninety-four of the three hundred patients, benign or malignant
lesions other than gastric polyps were found at operation.
In attempting to establish a correct differential diagnosis of a gastric lesion
there are other findings which should always arouse suspicion regarding the
possible existence of a malignant lesion. These include any recurrent gastric
ulceration, gastric (in distinction from gastrojeiunal) ulceration after previous
gastrcenterostomy or gastric resection, or significant change in the nature of
symptoms experienced by a patient in whom the diagnosis of a benign gastric
lesion, usually an ulcer, has been made previously. The roentgenologist is of
greatest help in establishing a diagnosis of gastric cancer, but he is not infallible
any more than anyone else, and it should be considered that there is at least a
10 per cent. chance of error in his differential diagnosis of benign or malignant
gastric ulcer. In addition, rcentgenologic diagnosis should be viewed with
suspicion when "persistent narrowing" is reported in the stomach and when
duodenal ulcer or "pyloric obstruction" is reported in the presence ofachlorhydria
or definite hypochlorhydria. It hardly seems necessary to state that Ino patient
should be treated medicallv for symptoms presumably caused by benign peptic
ulceration without the benefit of rcentgenologic examination of the stomach and
duodenum.
CYTOLOGIC STUDY OF GASTRIC WASHINGS.
A diagnostic procedure which has received increasing attention during recent
years is that of cytologic study of the gastric content. Various techniques have
been employed to obtain specimens of gastric content which are suitable for
microscopic examination and most likely to perrnit an accurate diagnosis.
Experiences reported in the literature vary with the type of patient studied, the
methods and procedures employed, and the experience of the cytologist. Seppala
(1961) summarized thirty-six different reports, including the more significant
studies made from 1947 to 1961. The largest series is that of Schade (1960), who
reported a total of 3,280 examinations. He used the saline lavage technique, and
reported that 90.5 per cent. of 258 cases of gastric carcinoma were correctly
diagnosed. False positive cytologic reports were made in 5 per cent. of the non-
malignant cases. Seppala (1961) reported in his own study of 736 patients that
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Kcytologic examination gave findings indicative of malignant disease in 80.5 per
cent. of patients with gastric cancer and a false positive rate of 1.9 per cent.
Our experience (Rovelstad, unpublished), last reviewed in 1960, is more modest
and does not reveal so high a degree of accuracy. A correct positive diagnosis of
gastric cancer was made in 17 of 25 patients (68 per cent.). No false positive
reports were obtained in a larger control group. Actually, in our entire group
of 142 patients, we found only one or possibly two patients in whom cytologic
studv made a significant contribution to diagnosis and management. Perhaps, as
our experience grows and methods improve, this type of study will prove to be
of greater value, although in 370 patients studied to date and admittedlv
incompletely reviewed, we have seen little to offer promise of greater expectations
from this procedure (Rovelstad, 1960).
SURGICAL TREATMENT.
When exploration shows gastric carcinloma, the surgeon must decide the
procedure of choice. This decision will be based not only on the findings, such
as local extension of the growth or the presence of metastasis, but also on his
experience with and philosophy of the surgical treatment of cancer. While it is
difficult to be dogmatic regarding surgical indications, because of the numerous
factors that must be considered in individual patients, my associates and I have
followed certain general principles which I will mention before results of
treatment are reviewed.
If the lesion is confined to the stomach, except perhaps for extension to regional
lvmph nodes, operation with hope of cure is undertaken. If the lesion can be
completely removed by subtotal gastric resection, leaving at least a portion of
the stomach attached to the cesophagus, this is done. Such a procedure routinely
involves removal of the greater omentum and dissection of all areas of regional
lymphatic drainage. The spleen has not always been removed when the lesion
involves onlv the distal portion of the stomach, although there is evidence to
suggest that removal is advisable (Fly et al., 1956). For lesions in the proximal
portion of the stomach the spleen is routinely removed. Total gastrectomy, which
always includes splenectomy, is reserved for the patient in whom subtotal
gastrectomy will not remove all areas of malignant involvement. Over the years
my associates and I have performed total gastrectomy in 18 to 20 per cent. of
patients in whom gastric malignant lesions have been resected. Total gastrectomy
is not employed when it is apparent that, at most, it would be only a palliative
procedure. No portion of the pancreas is removed unless findings at operation
suggest extension to this region.
More difficult surgical decisions may be required when the growth has extended
beyond the stomach and perhaps has involved the transverse colon, pancreas,
liver, retroperitoneal tissues, or other near-by structures. It has been our practice
to remove the growth en nmasse under these circumstances when, in the opinion
of the surgeon, this can be done in a complete manner. In some patients it is
difficult or impossible to be sure of this point until some mobilization of the
lesion has been accomplished. Local extension may be responsible for considering
134a lesion inoperable, but this is not often the case. Although it seems unlikely
that more and more radical operations will be responsible for great increase in
survival rates, it is our belief that whenever a malignant gastric lesion can be
completely removed, by any reasonable procedure, this should be done.
When abdominal exploration reveals nmultiple hepatic or other distant metastasis,
the opportunity for cure probably has passed. Under these circumstances, it is
not our practice to proceed with a radical operation. Palliative partial gastric
resection is performed if the nature and extent of the growth permit this
procedure to be done in a reasonable manner and without the necessity of total
gastrectomy. Removal of ani obstructing or blecding carcinoma situated in the
distal part of the stomach may afford considerable palliation. Gastroenterostomy
nmay be used in other cases if resection of the lesion does not seem reasonable
and if some degree of obstruction exists; however, the amount of palliation
obtained by this operation is less than that obtained if the growth is removed.
Other procedures such as gastrostomy, jejunostomy, or insertion of a plastic
tube through the site of an obstructing gastric growth are seldonm employed.
In patients in whom the growth is not removed, irradiation or the use of anti-
cancer drugs may be employed. While these modalities of therapy have provided
significanit palliation for some patients, to date this has not been true for the
majority. In our cxpericnce, usc of 5-fluorouracil has givenI temlporary subjectivc
improvement in approximately half of the patients with carcinoma of the stomach
in whom it has been used and objective evidence of improvenment in about a
fourth of them (Reitemeier and Moertel, unpublished). Reactions to this treat-
ment may be unfavourable, and it is not recommended indiscriminately. It is
hoped that more effective drugs may become available.
In operation for gastric cancer it is important to resect portions well above
and below any extension of the malignant process in the stomach or duodenunm
and to remove regions of possible lymphatic involvement. Except for patients
in whom there is an unusual degree of mucosal or submucosal spread of gastric
carcinoma, the surgeon usually can form a fairly reliable opinion of the upper
limit of extension of the growth by careful palpation and inspection of the
stomach. As additional help in this regard, the surgical pathologist routinely makes
multiple frozen sections of the upper and lower lines of resection to determine
whether there is anv microscopic evidence of malignancy. While information
provided by this means may not be completely reliable, it has been our experience
that it is seldom in error. Multiple areas of neoplastic involvement in the stomach
may occur, but this is uncommon in the absence of gross evidence of neoplasm.
It is difficult to say specifically how far above or below a growth the line of
resection should be placed. In this regard a study by ReMine and associates
(1953) is of interest. In this wvork an effort was made to deternine any differences
in the surgical specimens which were removed from two different groups of
patients. All patients in both groups had gastric resection perfornled for gastric
carcinoma with metastatic involvenment of regional lymph nodes. All patients in
one group lived five or more years after operation, and all patients in the other
group survived operation but died within one year. Measurements made between
135the line of resection and the nearest edge of the lesion both above and below the
growth, although virtually identical in both groups, averaged slightly longer for
those patients who survived less than a year than for those who survived five
years or nmore. From these data it wvould appear that removal of excessive
amounts of uninvolved stomach does not improve prognosis for the patient witl
gastric cancer.
TABLE 1.
LoCAIION OF ME;rASTrATIc LYMlPH NODES IN PAriENTS WI11T SHIORT-TERNI
AND LONG-TERM SURVIVAL AFTER GASTRIC RESECTION.
SURVIVAL OF PATIENTS,
PER CENT.
LOCATION OF INVOLVED NODES Long-term* Short-termt
Lesser curvature only - - - 64.6 ... 38.3
Greater curvature only - - - 14.8 ... 2.9
Both curvatures - - - - 20.6 ... 58.8
Subpyloric region- - - - 5.9 ... 70.6
*All patients lived five or more years after operation.
-1 All patients survived operation but died within onie year
Of particular interest in this study were the findings in reference to involvemenit
of lymph nodes (Table 1). The number of lymph nodes involved and their
location proved to be significant in relation to length of postoperative survival.
Involvement of lynmph nodes along only the lesser or greater gastric curvature
was noted more frequently in the group of long-term survivors than among the
short-term survivors. The opposite was true when niodes along both curvatures
were involved. Of particular significance was the finding that subpyloric nodes
were involved in only 5.9 per cent. of the long-term survivors whereas this
finding was present in 70.6 per cent. of the short-term survivors. Since this study
we have given nmore attention to complete removal of all lymph nodes in the
subpyloric area.
Other studies of importance to the surgeon include those which have demon-
strated the frequency of spread of gastric cancer into the duodenum (Coller
et al., 1941; Castlemana 1936). Marvin (1947) studied surgical specimens removed
from one hundred patients in whom gastric resection had been performed for
gastric carcinoma wvhich involved the prepyloric portion of the stomach.
Microscopic evidence of extension into the duodenuml xvas found in 38 per cent.
of this entire group. This extension was not always apparent grossly. The need
to remove several centimetres of duodenum whenever the prepyloric portion
of the stomach is involved with carcinoma is apparent. Spread from a gastric
cancer to splenic hilar nodes has been reported to occur in 17.5 to 36.9 per cent.
of cases.
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the pathologic characteristics and the methods of spread of the lesion to be
removed. Details of surgical technique will not be reviewed, but it might be
emphasized that proper routine operation for cancer of the stomach includes
complete removal not only of the lesion itself but also of all areas of primary
lymphatic drainage, especi-ally those around the origin of the left gastric arteries
and those in the duodenohepatic area, the region of the head of the pancreas,
the hilus of the spleen, and the omentum.
For partial gastrectomy I prefer the posterior Hofmeister-Polya type of
anastomosis with attachment of the distal limb of the jejunum to the greater
curvature of the stomach. When high subtotal gastrectomy is performed, a
posterior anastomosis may not be feasible, and the jejunal loops are then brought
anterior to the transverse colon. Adequate removal of the proximal portion of
the duodenum and subpyloric lymph nodes does not usually pe'rmit a Billroth
I type of anastomosis under favourable circumstances. Operative mortality rates
associated with subtotal gastrectomy performed for cancer have averaged about
6 to 7 per cent. during recent years.
When total gastrectomy is performed, end-to-side cesophagojejunostomy with
an entero-anastomosis is the routine procedure. It is varied only under special
circumstances. The anastomosis between the jejunal limbs, in addition to providing
drainage of the proximal limb, is helpful in preventing reflux of duodenal content
into the cesophagus, which might produce cesophagitis. A Roux-Y type of
end-to-end cesophagojejunostomy is employed if the mesentery of the jejunum
is short and does not permit establishment of an end-to-side cesophagojejunostomy
without tension on the anastomosis. End-to-end oesophagoduodenostomy is used
infrequently because adequate removal of the duodenum usually does not make
such an anastomosis feasible, and, in addition, cesophagitis may result from reflux
of duodenal content under these circumstances. We have had practically no
experience with use of a segment of colon or jejunum interposed between the
cesophagus and duodenum.
Inasmuch as no patient with cancer of the stomach has been cured except by
removal of the lesion, so far as I know, it is important that every patient with
cancer of the stomach be considered a prospect for operation unless definite
objective findings, such as distant metastasis, indicate the virtual impossibility
of total surgical removal of the malignant process. "Operability rate" may be
defined as the ratio (expressed in per cent.) of the number of patients subjected
to laparotomy to the total number of patients with the diagnosis of cancer whose
lesion was considered too far advanced to warrant even surgical exploration.
A review of our experience in this regard indicates operability rates of 60,-80,
and 90 per cent. for the years 1907 through 1939, 1940 through 1949, and 1950
through 1959, respectively. Thus, in recent years, only about 10 per cent. of
patients with gastric cancer are not afforded the possible benefits of abdominal
exploration.
Obviously, the surgeon always endeavours to resect the lesion at operation,
if this seems to be a reasonable procedure. The "resectability rate," as used in
137
Lthese data, may l)e defined as thc ratio of patients (expressed as per cent.) in
whom gastric cancer is resected to the total number of patients in whom operation
is performed. It is noted that this rate has increased from 45.5 per cent. during
the years 1930 through 1939 to 60.8 per cent. during the years 1950 through
1959 (Table 2). Unfortunately, the reasonl for this increase in proportioln of
TABLE 2.
RSECE1cABILInl RArI: OF GASTRIC CAN`CFR IN SUCCESSIVEv PERIODS
TO'1'Al,
PERIOI) OPERAT1IONS RESiF.CIIONS
PERIFORMID Num11ber Pcr Cenit.
1907-1919 ... 1902 ... 760 ... 40.0
1920-1929 ... 2456 ... 1146 ... 46.7
1930-1939 ... 2301 ... 1048 ... 45.5
1940-1949 ... 2945 ... 1638 ... 55.6
1950-1959 ... 2213 ... 1345 ... 60.8
TorAL - - 11817 ... 5937 ... 50.2
patients for whonm resection is perfornmedi is nlot that less-advanced lesionls have
been seen. This is evidenced by the fact that the percenltage o)f cases with lynmph
node involvemenit is greater at present thani it w\,as in the ealrlier years. This is
inmportant in relationi to interpretationi of reported survival rates after operation
for these years.
OPERATIVE MORTrAITT].
{!';Although the risk of operation for a patient with gastric cancer has been
loWered significantly during the past fifty years, this declile in operative
mortality has been much less nmarked in the last two decades than it was in the
prevfious three decades. This is no doubt true of many surgical procedures which
have been performed during the sanme period. For exanmple, for the period 1907
through 1939 the operative mortalitv rate (all hospital deaths) for partial
gastrectomy for cancer was 16.0 per cenit. and that for total gastrectomv wvas
65.6 per cent. In contrast, from 1940 through 1959 the operative mortality rate
for partial gastrectomy dropped to 6.6 per cent. and that for total gastrectomy
to 18.6 per cent. During the years 1950 to 1960 the operative mortality rates for
partial and total gastrectomy were 6.7 per cent. and 15.4 per cent. respectively.
Some surgeons have reported rather low, operative rates for total gastrectomlly
138in relatively snmall series of cases. In our experience the risk of this operation
has always remained definitely higher thani that for partial gastrectomy.
Other factors which influeince operative mortality for patients with cancer of
the stomach, but which are not limited to patients with cancer of the stomach,
include age and sex. Operative risk increases with age and has always been
lower for wonmen thani for men. Thus, from 1950 through 1959 the risk for all
forms of gastric resection for cancer was 6.2 per cent. for females and 8.2 per
cent. for males. Operative risk increases somewhat as the size of the lesion increases
and is higher when the lesion is in the cardia than when it is in the more distal
part of the stomach. The operative risk is also higher for patients who have type C
lesions (Dukes' classificationi) than for those with types A or B. A persisting
observation over the vears has been that operative mortality is higher among
patients with achlorhydria than among those who have free hydrochloric acid
in the gastric content. Thus, for the years 1940 through 1959 it was found that
the operative mortality rate for gastric resection in patients with achlorhydria
was 9.1 per cent.; for patients who had free hydrochloric acid up to thirty clinical
units the mortality rate was 6.8 per cent., and for those who had more than
thirty units the mortality rate was 2.1 per cent. There are no doubt many reasons
for the variations in mortality rates which have been mentioned, many of which
involve the realm of speculation or assumption but all of which have interesting
connotations.
SURVIVAL RATES.
In our experience the two most important factors which influence survival
rates after resection for gastric cancer are (1) the grade of the lesion and (2) the
presence or absence of lymph node involvement. Thus, for 1950 through 1954
it was found that 57.9 per cent. of patients without metastasis to the lymph nodes
survived five or more years after gastric resection in contrast with only 14.2
per cent. of those with metastasis to the lymph nodes. The influence of the grade
of the lesion on survival rates is evidenced by the fact that for the same period,
1940 through 1954, 53 per cent. of patients with lesions of grade 1 or 2 survived
five or more years after operation in contrast with only 26 per cent. of those
with lesions of grade 3 or 4. The poorest prognosis occurs when there is a
high-grade lesion with associated involvement of lymph nodes. Thus, only 12.1
per cent. of 692 patients who had resection, in the years 1940 through 1954, of
a grade-4 lesion with lymph node involvement survived five years or more after
operation. It is important, however, to realize that at least a few patients with
this type of lesion survive for an appreciable time after operation. The situation
is not a hopeless one.
Certain other factors such as the size and location of the lesion influence the
survival rate after resection but to less degree than the grade and presence or
absence of lymph node involvement. Thus, the five-year survival rate decreases
as the size of the lesion increases. It was found to be higher when the lesion
was situated on the lesser curvature of the stomach, in contrast with other areas
in the stomach. It has also been observed that the five-year survival rate decreases
as the gastric secretory level decreases.
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MTABLE 3.
FIVE-YEAR SURVIVAL RATES AFTER GASTRIC RESECTION IN DIFFERENT PERIODS.
LivED FIVE OR MORE YEARS
PERIOD PATIENTS AFTER LEAVING HOSPITAL
TRACED Number Per Cent.
1907-1919 ... 636 ... 174 ... 27.4
1920-1929 ... 970 ... 299 ... 30.8
1930-1939 ... 854 ... 258 ... 30.2
1940-1944 ... 678 ... 253 ... 37.3
1945-1949 ... 808 ... 255 ... 31.6
1950-1954 ... 701 ... 207 ... 29.5
Survival rates according to various periods are shown in Table 3. With the
exception of one five-year period (1940 through 1944), a remarkable similarity
in survival rates for all other periods is apparent. One should keep in mind the
facts, however, that operability and resectability rates have been increased as
time has passed, and that operative mortality rates have been lowered. Thus, a
higher percentage of patients with gastric cancer has undergone resection in
later years than in earlier years. This is true despite the fact that the incidence
of high-grade lesions and the presence of metastasis to the lymph nodes have
increased. It is not surprising that the five-year survival rate, which is calculated
on the basis of those patients who survived gastric resection, has not increased
over the years. The fact remains, however, that of one hundred patients in whom
the diagnosis of gastric cancer is made today, fifteen are expected to be alive
at least five years from now. This number represents only a slight increase, the
number being fourteen for the decade of 1940 through 1949. Although the
survival rate after resection has declined, the proportion of the total patients with
the diagnosis of gastric cancer who have survived for five years actually has
increased a bit. This apparent paradox is explained by the fact that a considerably
larger proportion of the total patients undergo resection than did in former
years.
The data as presented on survival rates include all patients who had a gastric
cancer resected, whether by subtotal or total gastrectomy. In a recent study
of 275 patients who underwent total gastrectomy for gastric cancer and survived
the operation, it was found that 14.9 per cent. were alive three years later,
9.9 per cent. five years later, and 7.9 per cent. ten years later. These data are
similar to those reported in earlier studies (Fly et al., 1958; ReMine and Priestley,
1952).
SUMMARY.
National differences in the incidence and trends of incidence of gastric
carcinoma might offer some clues regarding rtiologic factors of this disease if
thev could be properly evaluated. Although the relationship between "tumour
140aggression" and lost resistance is an important factor in determining the prognosis
for the patient who has cancer of the stomach, it is not the only factor to be
considered. Early diagnosis and treatment also may influence prognosis. Principles
of surgical treatment for gastric cancer are reviewed as are factors which influence
operative mortality and survival rates. During recent years it has been found
that of one hundred patients in whom the diagnosis of cancer is made, fifteen
may be expected to be alive five years later if appropriate surgical treatment is
carried out.
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